| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8,200 | $30 | $278.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 25,510 | $10 | $255.1K |
| J3262 | Injection, tocilizumab, 1 mg | 41,490 | $10 | $207.4K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,330 | $30 | $133.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 530 | $80 | $44.4K |
| J0897 | Injection, denosumab, 1 mg | 1,620 | $20 | $29.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 230 | $90 | $21.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 210 | $50 | $10.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 40 | $110 | $4.9K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 150 | $20 | $3.1K |